This is a snippet of the transcript, sign up to read more.
For a long time, Deere could drive a tractor straight, automatically turn it around at the end of a row, and plot a path. These are nearly all the components needed for an automated tillage solution, which Deere announced at CES in early January. However, they weren't fully integrated yet. Deere is now knitting these automations into true autonomy.
This is a snippet of the transcript, sign up to read more.
Regarding AI, machine learning, and Blue River-type technologies, Deere is commercializing them. Deere has studied millions of photos of weeds versus healthy agricultural products and can distinguish between them. This capability is essential for automatically spraying to kill weeds without harming plants, as seen in See & Spray. Deere is turning the corner by offering truly autonomous solutions and profitably using AI.
This is a snippet of the transcript, sign up to read more.
That's a great question, and I think it's the right one to be asking. I'll try to provide some context without belaboring the point. Deere has some really terrific value-added solutions that truly work and offer value. For instance, Deere has published information in the past few months about what it accomplished with See & Spray last year. It covered about a million commercial acres, and See & Spray delivered around $16 per acre of value while charging the farmer approximately $4 per acre to use the solution. These are just round numbers, but that's real value.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research